Elon Musk’s neurotechnology company, Neuralink, is preparing to launch a new trial in October aimed at helping people with speech impairments translate their thoughts directly into text using a brain implant. The company’s president, Dongjin Seo, announced the initiative during a recent talk in Seoul, according to a report by Reuters.
Blindsight, the experimental vision-restoring implant by Elon Musk’s brain-chip startup, Neuralink, has received the U.S. Food and Drug Administration’s (FDA) "breakthrough device" designation, according to the company.
Neuralink has successfully implanted a chip in the brain of their first human patient earlier this week, as per Elon Musk, founder of the brain-chip startup.
